SHEPHERD THERAPEUTICS

Lobbying client · Massachusetts · filed 2025 to 2026

rare cancer R&D

$0 Reported spend

6 Filings counted

1 Firms hired

0 Bills named

Spend is reported income plus in-house expenses across 6 filings. Everything on this page is grouped by the client's LDA id (187207), not by name.

Firms hired 1

G2G CONSULTING $0 6 filings

Reported by year 2 years

2026 $0 2 filings
2025 $0 4 filings

Issues lobbied 4

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 4

HOUSE OF REPRESENTATIVES 6
SENATE 6
Health & Human Services, Dept of (HHS) 4
Centers For Medicare and Medicaid Services (CMS) 1

Recent filings 6 total

Q2

G2G CONSULTING

2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · posted Jul 20, 2026

View → Q1

G2G CONSULTING

1st Quarter (Jan 1 - Mar 31) 2026 · House · Senate · posted Apr 16, 2026

View → Q4

G2G CONSULTING

4th Quarter (Oct 1 - Dec 31) 2025 · House · Senate · posted Jan 20, 2026

View → Q3

G2G CONSULTING

3rd Quarter (July 1 - Sep 30) 2025 · House · Senate · posted Oct 14, 2025

View → Q2

G2G CONSULTING

2nd Quarter (Apr 1 - June 30) 2025 · House · Senate · posted Jul 13, 2025

View → Q1

G2G CONSULTING

1st Quarter (Jan 1 - Mar 31) 2025 · House · Senate · posted Apr 21, 2025

View →

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.